BOTHELL, Wash., March 1, 2022 /PRNewswire/ -- BioLife Solutions, Inc. /zigman2/quotes/207858501/composite BLFS +5.77% ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction products and services for the cell and gene therapies (CGT) and the broader biopharma markets, today announced Mike Rice, Chairman and CEO, Rod de Greef, President and COO, and Troy Wichterman, CFO, are scheduled to present at both the Cowen and KeyBanc Investor Conferences in March 2022.
Annual Health Care Conference (Virtual)
Wednesday, March 9 [th] 12:50-1:20pm ET
KeyBanc Life Sciences & MedTech Forum
Wednesday, March 23 [rd] 4:30pm ET
About BioLife Solutions
BioLife Solutions is a leading supplier of class-defining bioproduction tools and services for the cell and gene therapy and broader biopharma markets. Our tools portfolio includes our proprietary CryoStor ® and HypoThermosol [�’] biopreservation media for shipping and storage, the ThawSTAR ® family of automated, water-free thawing products, evo ® cold chain management system, high capacity cryogenic storage freezers , Stirling Ultracold mechanical freezers, SciSafe biologic storage services, and Sexton Biotechnologies cell processing tools. For more information, please visit www.biolifesolutions.com , www.scisafe.com , www.stirlingultracold.com , or www.sextonbio.com and follow BioLife on Twitter .
Media & Investor Relations
At the Company
Chief Financial Officer
LHA Investor Relations
SOURCE BioLife Solutions, Inc.
Is there a problem with this press release? Contact the source provider Comtex at email@example.com. You can also contact MarketWatch Customer Service via our Customer Center.
Copyright (C) 2022 PR Newswire. All rights reserved